Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide/clindamycin topical gel in the treatment of patients with moderate to severe rosacea

scientific article published in May 2004

Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide/clindamycin topical gel in the treatment of patients with moderate to severe rosacea is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1365-4632.2004.02283.X
P698PubMed publication ID15117375

P2093author name stringSharon Levy
Ronald Savin
George Vamvakias
James Leyden
Debra Breneman
Christine VandePol
P2860cites workEfficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studiesQ44467246
P433issue5
P407language of work or nameEnglishQ1860
P304page(s)381-387
P577publication date2004-05-01
P1433published inInternational Journal of DermatologyQ15752742
P1476titleDouble-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide/clindamycin topical gel in the treatment of patients with moderate to severe rosacea
P478volume43

Reverse relations

cites work (P2860)
Q28069143Anti-inflammatory and Immunomodulatory Effects of Antibiotics and Their Use in Dermatology
Q33938459Effective and evidence-based management strategies for rosacea: summary of a Cochrane systematic review
Q24186383Interventions for rosacea
Q24235769Interventions for rosacea
Q24246629Interventions for rosacea
Q90751280Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments
Q34481841Interventions for rosacea: abridged updated Cochrane systematic review including GRADE assessments
Q35410266Update on the management of rosacea
Q33509787Updates on the pathophysiology and management of acne rosacea
Q45924112[Topical therapy of rosacea].